Paige Kelly is an Associate Director at Stern IR. Since joining the firm in 2019, she has gained IR experience across a wide range of biotechnology companies in various therapeutic areas including oncology and rare disease, radiopharmaceuticals, gene editing and gene therapy, as well as CNS, autoimmune and metabolic disorders. As someone who has directly benefitted from therapeutic innovations, Paige is passionate about patient advocacy and helping biotechnology companies impact people’s lives for the better. Throughout her time at Stern IR, she has worked with companies on multiple financings such as IPOs, SPACs, late-stage private rounds, and other alternative raises.
Paige graduated from Georgetown University with an A.B. in Psychology and secondary degrees in both Biology and Disability Studies. While at Georgetown, she worked as a student research assistant at the Developmental Cognitive Neuroscience Lab to research the effect of pediatric obesity on executive functioning. Born and raised in NYC, Paige still loves exploring the ever-evolving restaurant scene and spending weekends in Central Park with her labradoodle.
